financetom
Business
financetom
/
Business
/
China's Baidu beats quarterly revenue estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
China's Baidu beats quarterly revenue estimates
Aug 23, 2024 12:11 AM

Aug 22 (Reuters) - Search engine giant Baidu ( BIDU )

reported quarterly revenue above market estimates on

Thursday, signaling some recovery in the Chinese advertising

market.

Revenue in the second quarter was 33.93 billion yuan ($4.67

billion), compared with analysts' average estimate of 33.55

billion yuan, according to LSEG data.

($1 = 7.14 Chinese yuan renminbi)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Netclass Technology buys Japan's Createsolutions to strengthen market position in Asia
BRIEF-Netclass Technology buys Japan's Createsolutions to strengthen market position in Asia
Mar 10, 2025
March 10 (Reuters) - NetClass Technology Inc ( NTCL ): * NETCLASS TECHNOLOGY INC. ( NTCL ) STRENGTHENS MARKET POSITION IN ASIA WITH STRATEGIC ACQUISITION OF JAPAN-BASED CREATESOLUTIONS CO., LTD. Source text: Further company coverage: ...
Market Chatter: Full Truck Alliance May Revisit Plan for Second Listing in Hong Kong
Market Chatter: Full Truck Alliance May Revisit Plan for Second Listing in Hong Kong
Mar 10, 2025
07:44 AM EDT, 03/10/2025 (MT Newswires) -- Full Truck Alliance ( YMM ) will actively re-examine and consider a listing in Hong Kong amid a rebound in investor interest and growing geopolitical tensions between China and the US, Reuters reported Monday, citing Chief Financial Officer Simon Cai. The Chinese company had initially planned a dual primary listing in Hong Kong...
Top Premarket Gainers
Top Premarket Gainers
Mar 10, 2025
07:44 AM EDT, 03/10/2025 (MT Newswires) -- Redfin (RDFN) shares soared 80% pre-bell Monday after the company agreed to be acquired by Rocket Companies (RKT) in a deal worth $1.75 billion. Checkpoint Therapeutics ( CKPT ) shares surged 67% after the company agreed to be acquired by India's Sun Pharmaceutical Industries for $4.10 per share in cash plus a contingent...
Novo Nordisk's CagriSema Meets Primary Endpoint in Phase 3 Trial
Novo Nordisk's CagriSema Meets Primary Endpoint in Phase 3 Trial
Mar 10, 2025
07:43 AM EDT, 03/10/2025 (MT Newswires) -- Novo Nordisk ( NVO ) said Monday that its phase 3 trial evaluating CagriSema -- a fixed-dose combination of cagrilintide 2.4 mg and semaglutide 2.4 mg --met its primary endpoint in 1,206 overweight or obese patients with type 2 diabetes. The trial showed a statistically significant and superior weight loss with CagriSema compared...
Copyright 2023-2026 - www.financetom.com All Rights Reserved